• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Choroidal neovascularization complicating photodynamic therapy for central serous retinopathy.

作者信息

Colucciello Michael

机构信息

South Jersey Eye Physicians, 509 South Lenola Road, Suite 11, Moorestown, NJ 08057, USA.

出版信息

Retina. 2006 Feb;26(2):239-42. doi: 10.1097/00006982-200602000-00027.

DOI:10.1097/00006982-200602000-00027
PMID:16467692
Abstract
摘要

相似文献

1
Choroidal neovascularization complicating photodynamic therapy for central serous retinopathy.脉络膜新生血管形成并发于中心性浆液性视网膜病变的光动力疗法。
Retina. 2006 Feb;26(2):239-42. doi: 10.1097/00006982-200602000-00027.
2
Retinal pigment epithelial tear weeks following photodynamic therapy with verteporfin for choroidal neovascularization secondary to pathologic myopia.
Retina. 2002 Oct;22(5):669-71. doi: 10.1097/00006982-200210000-00027.
3
Circulatory changes in the choroidal vasculature after verteporfin-based photodynamic therapy for choroidal neovascularization in age-related macular degeneration.基于维替泊芬的光动力疗法治疗年龄相关性黄斑变性脉络膜新生血管后脉络膜血管系统的循环变化
Retina. 2004 Aug;24(4):618-20. doi: 10.1097/00006982-200408000-00020.
4
Choroidal infarction following photodynamic therapy with verteporfin.
Arch Ophthalmol. 2005 Aug;123(8):1149-53. doi: 10.1001/archopht.123.8.1149.
5
Retinal pigment epithelial marginal retraction after photodynamic therapy for choroidal neovascularization in pathologic myopia.
Eur J Ophthalmol. 2008 Sep-Oct;18(5):841-4. doi: 10.1177/112067210801800533.
6
Photodynamic therapy for iatrogenic CNV due to laser photocoagulation in central serous chorioretinopathy.光动力疗法治疗中心性浆液性脉络膜视网膜病变中激光光凝所致医源性脉络膜新生血管
Ophthalmic Surg Lasers Imaging. 2009 Jul-Aug;40(4):405-8. doi: 10.3928/15428877-20096030-10.
7
Retinopathy associated with photodynamic therapy for treatment of idiopathic choroidal neovascularization.
Clin Exp Ophthalmol. 2006 Mar;34(2):184-6. doi: 10.1111/j.1442-9071.2006.01179.x.
8
Photodynamic therapy with verteporfin for classic choroidal neovascularization secondary to focal laser photocoagulation for radiation retinopathy.
Ophthalmic Surg Lasers Imaging. 2003 Nov-Dec;34(6):475-7.
9
Photodynamic therapy for the treatment of choroidal neovascularization secondary to rubella retinopathy.光动力疗法治疗风疹性视网膜病变继发脉络膜新生血管化
Am J Ophthalmol. 2002 Nov;134(5):790-2. doi: 10.1016/s0002-9394(02)01647-1.
10
Nonarteritic anterior ischemic optic neuropathy after photodynamic therapy for choroidal neovascularization.脉络膜新生血管光动力治疗后非动脉炎性前部缺血性视神经病变
Jpn J Ophthalmol. 2004 Jul-Aug;48(4):424-6. doi: 10.1007/s10384-004-0078-7.

引用本文的文献

1
Comparative efficacy of half-dose and one-third-dose photodynamic therapy in chronic central serous chorioretinopathy: a retrospective study.半剂量与三分之一剂量光动力疗法治疗慢性中心性浆液性脉络膜视网膜病变的疗效比较：一项回顾性研究
Int J Retina Vitreous. 2025 Mar 18;11(1):32. doi: 10.1186/s40942-025-00657-6.
2
Efficacy of dexamethasone implant in the management of chronic central serous chorioretinopathy without choroidal neovascularization.地塞米松植入物治疗无脉络膜新生血管的慢性中心性浆液性脉络膜视网膜病变的疗效
Indian J Ophthalmol. 2025 Jan 1;73(Suppl 1):S100-S106. doi: 10.4103/IJO.IJO_626_24. Epub 2024 Jul 11.
3
The role of inflammation in central serous chorioretinopathy: From mechanisms to therapeutic prospects.
炎症在中心性浆液性脉络膜视网膜病变中的作用：从机制到治疗前景
Front Pharmacol. 2024 May 21;15:1200492. doi: 10.3389/fphar.2024.1200492. eCollection 2024.
4
Changes in Aqueous Concentrations of Various Cytokines after Intravitreal Bevacizumab Injection for Chronic Central Serous Chorioretinopathy.慢性中心性浆液性脉络膜视网膜病变玻璃体内注射贝伐单抗后房水中各种细胞因子浓度的变化。
Korean J Ophthalmol. 2023 Dec;37(6):453-461. doi: 10.3341/kjo.2023.0005. Epub 2023 Oct 25.
5
Predictive factors for outcomes of half-dose photodynamic therapy combined with aflibercept for pachychoroid neovasculopathy.半剂量光动力疗法联合阿柏西普治疗厚脉络膜新生血管病变的疗效预测因素。
Graefes Arch Clin Exp Ophthalmol. 2023 Aug;261(8):2235-2243. doi: 10.1007/s00417-023-06030-3. Epub 2023 Mar 8.
6
Subthreshold micropulse laser photocoagulation versus half-dose photodynamic therapy for acute central serous chorioretinopathy.亚阈值微脉冲激光光凝与半剂量光动力疗法治疗急性中心性浆液性脉络膜视网膜病变。
BMC Ophthalmol. 2022 Mar 8;22(1):110. doi: 10.1186/s12886-022-02331-z.
7
Short-Term Effects of Photodynamic Therapy on Segmentation of Retinal Layers in Central Serous Chorioretinopathy.光动力疗法对中心性浆液性脉络膜视网膜病变视网膜层分割的短期影响
Adv Biomed Res. 2021 Nov 26;10:34. doi: 10.4103/abr.abr_79_20. eCollection 2021.
8
Risk factors of persistent subretinal fluid after half-dose photodynamic therapy for treatment-naïve central serous chorioretinopathy.初治中心性浆液性脉络膜视网膜病变半剂量光动力疗法后持续性视网膜下液的危险因素。
Graefes Arch Clin Exp Ophthalmol. 2022 Jul;260(7):2175-2182. doi: 10.1007/s00417-021-05531-3. Epub 2022 Jan 13.
9
Decrease in choroidal blood flow after half and one-third dose verteporfin photodynamic therapy for chronic central serous chorioretinopathy.慢性中心性浆液性脉络膜视网膜病变半剂量和三分之一剂量维替泊芬光动力疗法后脉络膜血流减少。
BMC Ophthalmol. 2021 May 31;21(1):241. doi: 10.1186/s12886-021-01980-w.
10
One-year results of half-dose versus one-third-dose photodynamic therapy in chronic or recurrent central serous chorioretinopathy.慢性或复发性中心性浆液性脉络膜视网膜病变半剂量与三分之一剂量光动力疗法的一年疗效比较。
BMC Ophthalmol. 2021 Jan 12;21(1):30. doi: 10.1186/s12886-020-01796-0.